Streetbeat News

Analyst Ratings

BEEM

Beam Global (NASDAQ:BEEM) reported Q2 losses of $(0.32) per share, beating the analyst consensus estimate of $(0.34) by 5.88%. This is a 14.29% decrease over losses from the same period last year. The company also reported quarterly sales of $17.82 million, beating the analyst consensus estimate of $15.00 million by 18.79%. This is a 379.26% increase over sales from the same period last year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 9:53 pm

BKYI

BIO-key Intl reported Q2 losses of $(0.16) per share, beating the analyst consensus estimate of $(0.23) by 30.43%. However, the company's quarterly sales of $1.93 million missed the analyst consensus estimate of $2.30 million by 16.13%. This represents a 0.93% decrease over sales of $1.95 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 9:44 pm

RUM

Culper Research has announced that it continues to maintain a short position on Rumble, as per their recent tweet.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 9:19 pm

VNRX

VolitionRX reported Q2 losses of $(0.14) per share, beating the analyst consensus estimate of $(0.15) by 6.67%. However, the company's quarterly sales of $216.31K missed the analyst consensus estimate of $270.00K by 19.89%. This represents a 444.15% increase over sales of $39.75K the same period last year.

Portfolio Pulse from vinayak@benzinga.com

August 14, 2023 | 9:19 pm

BIOC

Biocept, Inc. (NASDAQ:BIOC) announced that its CNSide cerebrospinal fluid assay was featured in two presentations at the 2023 SNO/ASCO CNS Cancer Conference. The presentations highlighted the potential of CNSide in detecting HER2 amplification in patients with solid tumors and leptomeningeal metastasis (LM), and its superiority in detecting leptomeningeal carcinomatosis (LMC) compared to traditional CSF cytology. The results suggest that CNSide could provide valuable information for treatment decision making and potentially improve survival.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 9:15 pm

IZEA

IZEA Worldwide reported Q2 earnings per share of $(0.07), beating the analyst consensus estimate of $(0.16) by 56.25%. The company also reported quarterly sales of $10.70 million, surpassing the analyst consensus estimate of $8.50 million by 25.88%. However, this represents a 14.92% decrease compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 9:08 pm

POL

Polished.com (AMEX:POL) reported Q2 earnings of $0.01 per share, missing the analyst consensus estimate of $0.03 by 66.67%. The company also reported quarterly sales of $87.80 million, missing the analyst consensus estimate of $136.70 million by 35.77%. However, these figures represent increases over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 9:03 pm

GSM

Ferroglobe (NASDAQ:GSM) reported Q2 earnings of $0.30 per share, beating the analyst consensus estimate of $0.13 by 130.77%. However, this is a 73.68% decrease from the same period last year. The company's quarterly sales were $456.44 million, missing the analyst consensus estimate of $469.45 million by 2.77%. This is a 45.71% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 9:01 pm

PGY

In the last quarter, Pagaya Techs (NASDAQ:PGY) received 6 bullish ratings and 1 indifferent rating from analysts. The company's average 12-month price target is $3.93, which has increased by 81.11% over the past month.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 9:00 pm

MUR

Analysts have provided various ratings for Murphy Oil (NYSE:MUR) within the last quarter, with a total of 3 bullish, 4 somewhat bullish, and 1 indifferent. The average 12-month price target for Murphy Oil is $50.88, representing a 4.31% decrease from the previous average price target of $53.17.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 9:00 pm